Oliver Treacy
Gaillimh, C, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Subconjunctival administration of allogeneic TNF-α/IL-1β licensed MSCs promotes an anti-inflammatory microenvironment in a murine model of severe alkali burn.
Journal: International immunopharmacology
Published: January 09, 2026
Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity.
Journal: International immunopharmacology
Published: November 18, 2025
Correction: Small extracellular vesicles secreted from TGF-β1-licensed mesenchymal stromal cells reduce inflammation-associated injury following corneal alkali burn.
Journal: Stem cell research & therapy
Published: September 20, 2025
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2025
The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment.
Journal: European journal of immunology
Published: April 10, 2025
Small extracellular vesicles secreted from TGF-β1-licensed mesenchymal stromal cells reduce inflammation-associated injury following corneal alkali burn.
Journal: Stem cell research & therapy
Published: April 02, 2025
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling.
Journal: iScience
Published: January 04, 2024
Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual Conference.
Journal: Cancers
Published: November 26, 2022
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis.
Journal: Oncoimmunology
Published: February 08, 2021
Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice.
Journal: Stem cell research & therapy
Published: January 20, 2021
Last Updated: 09/26/2026